Manulife (Manufacturers Life Insurance)
CGEM icon

Manulife (Manufacturers Life Insurance)’s Cullinan Oncology CGEM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
75,310
+58,488
+348% +$752K ﹤0.01% 1801
2025
Q4 		$174K Sell
16,822
-1,004
-6% -$9.06K ﹤0.01% 2580
2025
Q3 		$106K Sell
17,826
-1,203
-6% -$8.81K ﹤0.01% 2767
2025
Q2 		$143K Buy
19,029
+30
+0.2% +$241 ﹤0.01% 2673
2025
Q1 		$144K Sell
18,999
-5,826
-23% -$55.9K ﹤0.01% 2597
2024
Q4 		$302K Sell
24,825
-713
-3% -$10.2K ﹤0.01% 2448
2024
Q3 		$428K Buy
25,538
+10,363
+68% +$184K ﹤0.01% 2344
2024
Q2 		$265K Buy
15,175
+4,393
+41% +$93.5K ﹤0.01% 2476
2024
Q1 		$184K Buy
10,782
+90
+0.8% +$1.39K ﹤0.01% 2624
2023
Q4 		$109K Hold
10,692
– – ﹤0.01% 2792
2023
Q3 		$96.8K Hold
10,692
– – ﹤0.01% 2821
2023
Q2 		$115K Sell
10,692
-1,469
-12% -$15.6K ﹤0.01% 2803
2023
Q1 		$124K Hold
12,161
– – ﹤0.01% 2695
2022
Q4 		$128K Buy
12,161
+148
+1% +$1.8K ﹤0.01% 2727
2022
Q3 		$154K Sell
12,013
-314
-3% -$4.23K ﹤0.01% 2689
2022
Q2 		$158K Buy
12,327
+649
+6% +$7.36K ﹤0.01% 2768
2022
Q1 		$122K Sell
11,678
-2,634
-18% -$35.6K ﹤0.01% 2922
2021
Q4 		$221 Buy
14,312
+630
+5% +$12.6K ﹤0.01% 2838
2021
Q3 		$309K Buy
13,682
+5,805
+74% +$155K ﹤0.01% 2648
2021
Q2 		$203K Buy
7,877
+495
+7% +$15.2K ﹤0.01% 3093
2021
Q1 		$308K Buy
+7,382
New +$300K ﹤0.01% 2606

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CGEM Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Cullinan Oncology (CGEM) stake by 348% in Q1 2026, buying an estimated $752K and bringing the position to 75,310 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Manulife (Manufacturers Life Insurance) first reported a position in CGEM in Q1 2021 and has held it in 21 quarters since. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 75,310 shares of Cullinan Oncology worth $1.07M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 58,488 Cullinan Oncology shares in Q1 2026, an estimated $752K.
  • Cullinan Oncology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1801 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cullinan Oncology in Q1 2021 and has held it in 21 quarters since.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.